Health-related quality of life in patients with metastatic colorectal cancer treated with panitumumab in first- or second-line treatment

被引：0
|
作者：
L Bennett
Z Zhao
B Barber
X Zhou
M Peeters
J Zhang
F Xu
J Wiezorek
J-Y Douillard
机构：
[1] RTI Health Solutions,Department of Oncology
[2] Amgen Inc.,Department of Medical Oncology
[3] One Amgen Center Drive,undefined
[4] University Hospital Antwerp,undefined
[5] Centre René Gauducheau,undefined
[6] Boulevard J Monod,undefined
来源：
British Journal of Cancer | 2011年 / 105卷
关键词：
colorectal cancer; panitumumab; quality of life;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1495 / 1502
页数：7
相关论文
共 50 条
  • [1] Health-related quality of life in patients with metastatic colorectal cancer treated with panitumumab in first- or second-line treatment
    Bennett, L.
    Zhao, Z.
    Barber, B.
    Zhou, X.
    Peeters, M.
    Zhang, J.
    Xu, F.
    Wiezorek, J.
    Douillard, J-Y
    [J]. BRITISH JOURNAL OF CANCER, 2011, 105 (10) : 1495 - 1502
  • [2] Health-related quality of life in patients with metastatic colorectal cancer treated with panitumumab in first- or second-line treatment
    Bennett, L.
    Zhao, Z.
    Barber, B.
    Zhou, X.
    Peeters, M.
    Zhang, J.
    Xu, F.
    Wiezorek, J. S.
    Douillard, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] Metastatic colorectal cancer:: First- and second-line treatment in 2005
    Rougier, P
    Lepère, C
    [J]. SEMINARS IN ONCOLOGY, 2005, 32 (06) : S15 - S20
  • [4] First- and second-line therapy of metastatic colorectal cancer
    Terstriep, Shelby
    Grothey, Axel
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (06) : 921 - 930
  • [5] Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trial
    Petracci, Elisabetta
    Scarpi, Emanuela
    Passardi, Alessandro
    Biggeri, Annibale
    Milandri, Carlo
    Vecchia, Stefano
    Gelsomino, Fabio
    Tassinari, Davide
    Tamberi, Stefano
    Bernardini, Ilaria
    Accettura, Caterina
    Frassineti, Giovanni Luca
    Amadori, Dino
    Nanni, Oriana
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [6] Second-line treatment of patients with metastatic colorectal cancer
    Rougier, P
    Lepere, C
    [J]. SEMINARS IN ONCOLOGY, 2005, 32 (06) : S48 - S54
  • [7] Health-related quality of life and colorectal cancer-specific symptoms in patients with chemotherapy-refractory metastatic disease treated with panitumumab
    Dawn Odom
    Beth Barber
    Lee Bennett
    Marc Peeters
    Zhongyun Zhao
    James Kaye
    Michael Wolf
    Jeffrey Wiezorek
    [J]. International Journal of Colorectal Disease, 2011, 26 : 173 - 181
  • [8] Health-related quality of life and colorectal cancer-specific symptoms in patients with chemotherapy-refractory metastatic disease treated with panitumumab
    Odom, Dawn
    Barber, Beth
    Bennett, Lee
    Peeters, Marc
    Zhao, Zhongyun
    Kaye, James
    Wolf, Michael
    Wiezorek, Jeffrey
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2011, 26 (02) : 173 - 181
  • [9] Symptom burden & quality of life among patients receiving second-line treatment of metastatic colorectal cancer
    Mark S Walker
    Elaine Yu Pharm
    Jiandong Kerr
    Yeun Mi Yim
    Edward J Stepanski
    Lee S Schwartzberg
    [J]. BMC Research Notes, 5 (1)
  • [10] Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer
    Borner, MM
    Dietrich, D
    Stupp, R
    Moran, R
    Honegger, H
    Wernli, M
    Herrmann, R
    Pestalozzi, BC
    Saletti, P
    Hanselmann, S
    Müller, S
    Brauchli, P
    Castiglione-Gertsch, M
    Goldhirsch, A
    Roth, AD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (07) : 1759 - 1766
12345